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Abstract
Background: Anosmin-1, the protein implicated in the X-linked Kallmann's syndrome, plays a role
in axon outgrowth and branching but also in epithelial morphogenesis. The molecular mechanism
of its action is, however, widely unknown. Anosmin-1 is an extracellular protein which contains a
cysteine-rich region, a whey acidic protein (WAP) domain homologous to some serine protease
inhibitors, and four fibronectin-like type III (FnIII) repeats. Drosophila melanogaster Kal-1 (DmKal-1)
has the same protein structure with minor differences, the most important of which is the presence
of only two FnIII repeats and a C-terminal region showing a low similarity with the third and the
fourth human FnIII repeats. We present a structure-function analysis of the different DmKal-1
domains, including a predicted heparan-sulfate binding site.
Results: This study was performed overexpressing wild type DmKal-1 and a series of deletion and
point mutation proteins in two different tissues: the cephalopharyngeal skeleton of the embryo and
the wing disc. The overexpression of DmKal-1 in the cephalopharyngeal skeleton induced dosage-
sensitive structural defects, and we used these phenotypes to perform a structure-function
dissection of the protein domains. The reproduction of two deletions found in Kallmann's
Syndrome patients determined a complete loss of function, whereas point mutations induced only
minor alterations in the activity of the protein. Overexpression of the mutant proteins in the wing
disc reveals that the functional relevance of the different DmKal-1 domains is dependent on the
extracellular context.
Conclusion: We suggest that the role played by the various protein domains differs in different
extracellular contexts. This might explain why the same mutation analyzed in different tissues or in
different cell culture lines often gives opposite phenotypes. These analyses also suggest that the
FnIII repeats have a main and specific role, while the WAP domain might have only a modulator
role, strictly connected to that of the fibronectins.
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Background
Kallmann's syndrome (KS) is a heritable disorder charac-
terized by the association of anosmia or hyposmia, i.e. the
lack or reduction of the sense of smell, and hypogonado-
tropic hypogonadism [1]. These anomalies probably arise
from impaired targeting and migration of the olfactory
axons and of the neurons secreting the gonadotropin-
releasing hormone (GnRH), both originating in the olfac-
tory placode [2,3], or from alterations in the initial steps
of olfactory bulb differentiation [4]. KS patients have
aplasia or hypoplasia of olfactory bulbs and tracts, and
with less frequency display other symptoms, such as mir-
ror movements, unilateral renal aplasia and cleft lip/pal-
ate [5-7]. Notably, some of these symptoms are
attributable to defects in morphogenesis.
Up to now, only two of the genes involved in KS have
been identified: KAL-1 and KAL-2. KAL-1 is responsible
for the X-linked form of the disease and encodes an extra-
cellular matrix protein. This protein (anosmin-1) has a
peculiar domain composition, with a cysteine-rich (CR)
region at the N-terminus, followed by a whey acidic pro-
tein (WAP) domain and four fibronectin-like type III
(FnIII) repeats [8,9]. KAL-2 is the gene responsible for an
autosomal dominant form of KS and encodes the fibrob-
last growth factor type one receptor (FGFR1) [10].
Together, mutations in these two genes account for
approximately 30% of KS cases.
Functional studies on the role of KAL-1 have been ham-
pered by the failure to identify a mouse ortholog,
although KAL-1 homologs have been found in many dif-
ferent species, including invertebrates [11-13]. Experi-
mental evidences in different systems indicate that
anosmin-1, secreted by neurons in the olfactory bulb, is a
key factor controlling successful innervation and organi-
zation of the olfactory bulbs [14-18] and migration of
GnRH neurons [19]. Studies in C. elegans demonstrated a
role of the kal-1 gene in both epithelial morphogenesis
and neurite outgrowth and branching. Notably, these
processes were affected in kal-1 loss of function mutant
but also when kal-1 was overexpressed [11,12]. Using the
overexpression approach, it has also been demonstrated
that a single amino acid substitution in the first FnIII
repeat, which reproduces a mutation found in a KS patient
[20], abolished the axon branching activity but had no
effects on axon targeting activity of the protein. Another
mutation, which disrupted two of the four disulfide
bonds of the WAP domain, did not impair the overall
branching propensity of kal-1 but it abolished the poten-
tial to misroute axons [12,21]. On the basis of these
results, it was suggested that the branching activity and the
outgrowth activity of CeKal-1 are genetically separable.
In Drosophila only one kal-1 ortholog was found, which
encodes a protein smaller than vertebrate and worm
orthologs [12,13]. Drosophila melanogaster Kal-1 (DmKal-
1) has only two FnIII repeats, while the C-terminal region
displays low similarity with the third (32%) and the
fourth (36%) human FnIII repeats. During Drosophila
embryonic development, kal-1 is expressed in a complex
and dynamic pattern in cells involved in morphogenetic
processes or associated with sensory organs and is also
expressed in male-specific somatic gonadal precursors
(msSGPs) [22]. kal-1 is strongly expressed in some ecto-
dermal cells of the mandibular segment, which are prob-
ably involved in the formation of the head skeleton of the
embryo. In fact, kal-1 expression is reduced or abolished
in  Deformed  (Dfd) and cap-n-collar  (cnc) homeotic
mutants, which lack some components of the anterior
cephalopharyngeal skeleton [13].
In this article, we present a systematic structure-function
study of DmKal-1 using an overexpression approach. We
show that DmKal-1 can cause strong alterations in the
cephalopharyngeal skeleton of the larva when it is
expressed in cells that surround the head skeleton, sug-
gesting a role of kal-1 in the morphogenesis of this organ.
We did not characterize in further detail the possible func-
tion of kal-1 in the formation of the head skeleton, but we
utilized this phenotype to perform an in vivo molecular
dissection of the contribution played by the different
domains of the protein, expressing a series of mutated
forms of DmKal-1. In this analysis we looked for qualita-
tive differences in the phenotypes induced by the expres-
sion of the different mutant forms. We have also
expressed the wild type and the mutated DmKal-1 pro-
teins in another tissue, to test whether the functional rele-
vance of each single domain depends on the extracellular
context. We selected the adult wing, because it is very easy
to detect even small defects caused by alterations in the
morphogenetic processes leading to the final structure of
this organ. We have found that the expression of wild type
DmKal-1 causes several alterations in the wing develop-
ment, while the defects induced by the mutants suggest
that the activity of the protein is dependent on the extra-
cellular context. The binding activity of mutations in the
first FnIII repeat were also analyzed by in vitro transfection
experiments in COS-7 cells.
Results
kal-1 overexpression during the cephalopharyngeal 
skeleton formation determines alterations of the head 
skeleton structure
kal-1 is expressed in the second part of embryogenesis in
cells involved in morphogenetic processes such as germ
band retraction (GBR), dorsal closure (DC) and head
involution (HI) [13]. We found a strong expression in a
restricted group of ectodermal cells in the mandibular seg-BMC Genetics 2006, 7:47 http://www.biomedcentral.com/1471-2156/7/47
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ment during HI (Fig. 1A) [13], suggesting an involvement
of kal-1 in this morphogenetic process. The mandibular
segment gives rise to the anterior part of the cephalopha-
ryngeal skeleton, comprising the mouth hook base and
the lateralgräten [23]. To test a possible function of kal-1
in the formation of these structures, we overexpressed it in
the cells responsible for the formation of the head skele-
ton. To this purpose, we prepared transgenic lines that
express the kal-1 cDNA under the control of the UAS pro-
moter (P [UAS-kal-1]) (Fig. 2A) [24] and crossed them
with the 179y-GAL4 line [25]. In this transgenic line, the
transactivator is expressed during the second part of
embryogenesis, showing a ubiquitous distribution from
stage 13 to stage 16. In particular, during stages 15 and 16,
the GAL4 protein is abundant in the whole ectoderm
(data not shown). At stage 17, when the sclerotization of
the mouth parts takes place, the expression of 179y-GAL4
is detectable at the base of the mouth hooks and in the
cells surrounding the whole head skeleton (fig. 1B, C).
The P [UAS-kal-1] line was crossed with 179y-GAL4 and
we found that a consistent amount of eggs failed to hatch
(43%, n 226), while the surviving larvae showed a delay
of the hatching (data not shown). Using a transgenic line
with P [UAS-kal-1] insertions on the second and the third
chromosome (P [UAS-kal-1]II and III) ,  w e  o b t a i n e d  a
stronger phenotype with a greater amount of non hatch-
ing larvae (72%, n 193), suggesting a dose dependent
effect of the expression of kal-1 on the hatching process.
Cuticle preparations of embryos from the P [UAS-kal-1]II
and III line revealed appreciable head skeleton alterations,
but no other defects. The mouth hooks of a substantial
portion of kal-1  expressing larvae lacked the sclerotic
material that forms the base of the hook. The dorsal and
ventral processes of the hooks were variably reduced, leav-
ing only the anterior curved part in the individuals show-
ing the strongest phenotype (Fig. 1D, E). Since the mouth
hooks are necessary to open the operculum of the egg, this
may explain the failure of the egg hatching. With lower
penetrance, the whole cephalopharyngeal skeleton
showed a deformed structure probably due to a less scle-
rotized structure, especially the median tooth, the H-piece
and the lateralgräten (fig. 1D, E). These data demonstrate
that the formation of the sclerotized parts of the head skel-
eton is sensible to high level of DmKal-1 protein. There is
a perfect correlation between the expression pattern of the
179y-GAL4 driver in the cephalopharyngeal skeleton and
the components of the head skeleton, which show a
reduced sclerotization.
To prove the specificity of the head skeleton phenotype
induced by kal-1 expression, we tested if the expression of
the Neuroglian form Nrg180 [26], which contains five FnIII
domains, was able to induce a phenotype similar to that
produced by kal-1. The Neuroglian expressing larvae were
viable and able to hatch and did not show cephalopha-
ryngeal skeleton alterations (data not shown), suggesting
that a simple increase in FnIII containing proteins in the
matrix does not induce alterations of the head skeleton.
Taken together with the expression profile of kal-1 in the
mandibular segment, these data suggest an involvement
of kal-1 in some aspects of the formation of the head skel-
eton.
Structure-function dissection of DmKal-1
By using a neuronal phenotype induced by overexpres-
sion, it was shown that the C. elegans Kal-1 (CeKal-1) WAP
and FnIII domains seem to mediate different functions
[12]. We therefore decided to find out which domains of
DmKal-1 were required for the head skeleton phenotype
described above. A C-terminal truncated CeKal-1 protein,
missing part of the first FnIII domain and all the other
FnIII domains, did not induce any phenotype when
expressed in AIY interneurons [12]. We reproduced this
deletion (Fig. 2B), found in some human KS patients [20],
and the UAS-kal-1 [W200-STOP] construct was expressed
using the 179y-GAL4 driver. All the lines analyzed did not
show any phenotype (data not shown). We then repro-
duced another human mutation (nonsense mutation at
Q421) [20], which causes in Drosophila the deletion of the
C-terminal end of the protein, just after the second FnIII
repeat (Fig. 2C). The deleted sequence contains a pre-
dicted heparan-sulfate binding site (P441HKEKV446). Also
in this case, the expression of UAS-kal-1 [H384-STOP],
driven by 179y-GAL4, did not induce any phenotype (data
not shown), indicating that the C-terminal region is nec-
essary for the function of DmKal-1. We can not exclude,
however, that the deletion of the C-terminal domain(s)
may alter the stability of the protein. We then tested a spe-
cific point mutation in the first FnIII repeat, which mimics
a mutation at an equivalent position identified in a
human KS patient  (Fig. 2D)[20]. In C. elegans the same
missense mutation abrogates heparin dependent cell
adhesion and the ability of the protein to induce cell
axonal branching [12]. In addition, it was also demon-
strated that an equivalent mutation in the human anos-
min-1 affects the chemiomigration activity of the protein
on GN11 cells [19]. When expressed with the 179y-GAL4
driver, the UAS-kal-1 [N236K] construct produced pro-
found head alterations, including abnormal median
tooth development as well as mouth hook defects and a
skeleton with a less sclerotized structure. Surprisingly, the
Dmkal-1 [N236K] protein also induced HI defects (Fig.
3A). This mutant protein retained the ability to induce the
defects produced by the wild type DmKal-1 protein (Fig.
1E), but also altered the HI process, suggesting that it has
an additional activity in respect to the wild type protein.
Four different DmKal-1 [N236] lines were analyzed, and
all of them showed these phenotypes (Table 1). There was
a correlation between lethality penetrance and theBMC Genetics 2006, 7:47 http://www.biomedcentral.com/1471-2156/7/47
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kal-1 overexpression in the cells responsible for the formation of the cephalopharyngeal skeleton causes alterations of the scle- rotized components of the head Figure 1
kal-1 overexpression in the cells responsible for the formation of the cephalopharyngeal skeleton causes alter-
ations of the sclerotized components of the head. (A) Stage 16 wild type embryonic head. The kal-1 transcript is 
detected in the region of the gnathal lobes that will give rise to the anterior part of the cephalopharyngeal skeleton. (B) Sche-
matic representation of the cephalopharyngeal skeleton of a L1 Drosophila larva. MH mouth hook, MT median tooth, HP H-
piece, LG lateralgräten, DBr dorsal bridge, DP dorsal process, VP ventral process. (C) Fluorescence (left), bright-field (center), 
and merged (right) images of the expression in the cephalopharyngeal skeleton of a stage 17 embryo of the UAS-GFP reporter, 
driven by the 179y-Gal4 line. (D) Wild type stage 17 embryonic head cuticle. In the inset, a magnification of the mouth hooks. 
(E) Head cuticle of a stage 17 179y-Gal4/+; UAS-kal-1/+; UAS-kal-1/+ embryo. The head skeleton structure appears less sclero-
tized; principally the median tooth, the H-piece, and the lateralgräten, but also the dorsal bridge, the dorsal process, and the 
ventral process appear thinner than in the wild type. The mouth hooks lack the posterior part (inset).BMC Genetics 2006, 7:47 http://www.biomedcentral.com/1471-2156/7/47
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Schematic structure of Dmkal-1 and of the different mutant proteins analyzed Figure 2
Schematic structure of Dmkal-1 and of the different mutant proteins analyzed. (A) Wild type Dmkal-1. (B) Dmkal-
1 [W200-STOP]. (C) Dmkal-1 [H384-STOP]. (D) Dmkal-1 [N236K]. (E) Dmkal-1 [C127/128S]. (F) Dmkal-1 [C127/
128+N236K]. (G) Dmkal-1 [C85S]. (H) Dmkal-1 [R159T+R161L]. CR, Cysteine-rich domain; WAP, Whey Acidic Protein-like 
domain; FnIII, Fibronectin-like type III domain. Asterisks indicate the position of heparan-sulfate binding site consensus 
sequences. In gray the domains affected by mutations.BMC Genetics 2006, 7:47 http://www.biomedcentral.com/1471-2156/7/47
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number of larvae showing HI phenotypes. We can exclude
that the protein level of DmKal-1 [N236] is higher than
those of the wild type because even DmKal-1 lines pro-
ducing high lethality did not shown any HI phenotypes
(Table 1). Furthermore, all the other mutant lines affect-
ing the other domains never showed HI defects (data not
shown). Analyzing the UAS-kal-1 [N236K] lines that gave
the strongest HI phenotypes, we observed that a signifi-
cant part of the embryos displayed an incomplete GBR
(Fig. 3F, G). Since 179y-GAL4 also drives the expression in
the amnioserosa, this phenotype might be due to altered
adhesion between amnioserosa and germ band cells. The
GBR phenotype was not induced by the expression of the
wild type protein, also when we used the P [UAS-kal-1]II
and III line (Fig. 3F).
To determine whether the WAP domain was essential for
the induction of the head skeleton phenotype and for the
alterations in the HI process induced by the N236K sub-
stitution, we introduced a double substitution C-S in the
four-disulfide core motif both in the wild type protein
(UAS-kal-1 [C127/128S]) (Fig. 2E) and in the DmKal-1
[N236K] mutant protein (UAS-kal-1 [C127/
128S+N236K]) (Fig. 2F). The C127/128S substitution as
well as the C127/128S+N236K combination induced
alterations of the head skeleton similar to the wild type
DmKal-1 protein (Fig. 3B, C). This demonstrates that the
double substitution in the WAP domain does not alter the
ability of DmKal-1 to induce head skeleton phenotypes.
On the other hand, the alteration of the WAP domain sup-
presses the HI phenotype induced by the N236K muta-
tion. These experiments suggest that, like in C. elegans, the
Drosophila Kal-1 WAP domain is not essential for some
functions of the protein but that, nevertheless, the func-
tion of the fibronectins and of the WAP domain is strictly
interdependent, at least in this context.
At the N-terminus region of the DmKal-1 protein there is
a conserved CR region, containing four out of the eight
cysteines residues found in the human protein. We pre-
pared a UAS construct with the C-S substitution at posi-
tion 85 (UAS-kal-1 [C85S]) (Fig. 2G) to test the function
of this domain. We analyzed five different transgenic lines
but only one showed reduced viability and delay of hatch-
ing when crossed with 179y-GAL4, while the others did
not show any appreciable phenotype. The head skeleton
showed a thin structure, while the mouth hooks base
showed only a reduction of the dorsal process (Fig. 3D).
Increasing the UAS-kal-1 [C85S] copy number, we regis-
tered a small increase of the lethality, even though the
cephalopharyngeal skeleton phenotype was not as severe
as the phenotype induced by the wild type kal-1 gene. We
can formulate at least two possible explanations for this
result: it may depend on a lower activity of the DmKal-1
[C85S] protein or on a lower amount of the mutant pro-
tein produced in all the lines examined. Since we do not
have a specific antibody against Dmkal-1 we can not
exclude the second possibility. Anyway, it is worth noting
that a CR mutated form of DmKal-1 retains a significant
activity, at least in respect to the phenotype analyzed.
Cephalopharyngeal skeleton phenotypes induced by overex- pression of the different DmKal-1 mutant proteins Figure 3
Cephalopharyngeal skeleton phenotypes induced by 
overexpression of the different DmKal-1 mutant pro-
teins. (A, B, C, D, E) Head cuticle of stage 17 embryos. (A) 
Stage 17 179y-Gal4/+; UAS-kal-1 [N236K] embryo. The head 
skeleton structure appears less sclerotized and the median 
tooth is altered. Moreover, the mouth hooks (arrows) lack 
the posterior part and appear distant from the mid-line (dot-
ted line). (B) Stage 17 179y-Gal4/+; UAS-kal-1 [C127/128S] 
embryo. (C) Stage 17 179y-Gal4/+; UAS-kal-1 [C127/
128S+N236K] embryo. (D) Stage 17 179y-Gal4/+; UAS-kal-1 
[C85S] embryo. The mouth hooks base shows a reduction of 
the dorsal process. (E) Stage 17 179y-Gal4/+; UAS-kal-1 
[R159T+R161L] embryo. In the insets, a magnification of the 
hooks. (F, G)) Stage 13 embryos immunostained with anti-
Hind antibody. (F) 179y-Gal4/+; UAS-kal-1; UAS-kal-1 
embryo. GBR occurs normally. (G) 179y-Gal4/+; UAS-kal-1 
[N236K] embryo. The embryo shows an incomplete GBR 
process.BMC Genetics 2006, 7:47 http://www.biomedcentral.com/1471-2156/7/47
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Function of the fibronectins and of a predicted heparan-
sulfate binding site in the adhesion property and activity of 
DmKal-1
It is striking that the N236K mutation promotes addi-
tional phenotypes that are not induced by the wild type
protein, while in C. elegans the same mutation produces a
partial loss of function [12]. Since the fibronectin mutat-
edCeKal-1 protein looses the heparin-dependent cell
adhesion property of wild type CeKal-1, we decided to test
if the cell-binding activity of DmKal-1 was abolished by
the N236K substitution. First, we analyzed the cell adhe-
sion property of the wild type DmKal-1 protein, tran-
siently expressing a myc-tagged form of DmKal-1 in COS-
7 cells. We performed immunofluorescence analysis on
unpermeabilized cells, using a monoclonal anti c-myc
antibody (9E10). As shown in Fig. 4A, DmKal-1-Myc
localized at the cell surface of the transfected cells, con-
firming that also the Drosophila ortholog of anosmin-1 is
secreted in the extracellular space and is able to bind to
the outer side of the cell membrane. Western blot analysis
of cell extracts revealed the presence of two bands, repre-
senting different modified forms of Dmkal-1 (Fig. 4D). In
fact the molecular weight of the two bands exceeds the
theoretical weight of 60 kD of DmKal-1-Myc. We found
that DmKal-1-Myc was abundant in the medium (Fig. 4D
and material and methods), where only one isoform of an
even higher molecular weight was detected, suggesting
that the protein is further modified. The DmKal-1-Myc
protein was released from the cell surface when the cells
were incubated in fresh medium for 30 min (Fig. 4D),
indicating a weak binding of DmKal-1-Myc to the cell sur-
face. When the cells were further incubated for 30 min in
a medium containing 100 μg/ml of heparin, an additional
small amount of DmKal-1-Myc protein was released from
the cell surface (Fig. 4D). All the three forms of the
DmKal-1-Myc protein can be detected on the cell surface,
indicating that the further modification of the protein
occurs on the outer side of the cell membrane.
Like DmKal-1-Myc also DmKal-1-Myc [N236K] showed a
cell surface localization in transfected COS-7 cells (Fig.
4B). The mutant protein was released in the fresh medium
and in the heparin-containing medium with a pattern that
was identical to the wild type protein (Fig. 4D). This sug-
gested that the N236K substitution does not disrupt
DmKal-1 interaction with the cell surface. In contrast, the
equivalent mutation in C. elegans completely abolishes
the interaction of CeKal-1 with the cell membrane [12].
These results might explain why DmKal-1 [N236K] main-
tains its biological activity in vivo. A possible structural
basis for the different behavior of the two proteins can be
found when comparing the sequence of the first fibronec-
tin of anosmin-1 in different species (Fig. 5). In all the ver-
tebrates and in some of the invertebrates, there is a
conserved heparan-sulfate binding site consensus
(XBBXBX where B is a basic residue and X any other one)
near to the site of the mutation [27]. This sequence is
present also in C. elegans, even if it is only partially con-
served. In D. melanogaster, as in B. mori, this heparan-sul-
fate binding site is absent. A complete consensus sequence
for a heparan-sulfate binding site is instead present at the
N-terminus of the first Drosophila fibronectin (Fig. 5).
We then hypothesized that the removal of the predicted
heparan-sulfate binding site might inactivate the protein.
We changed the F157RRSRG162 site to an F157RTSLG162,
substituting two basic residues. We tested if this protein
retained the binding property to the cell surface, transfect-
ing COS-7 cells with a Myc tagged form of DmKal-1
[R159T+R161L] (Fig. 2H). We found that the mutant pro-
tein still localized to the cell surface (Fig. 4C), with a dis-
tribution pattern similar to the wild type protein (Fig.
4D). We also created transgenic lines bearing a UAS-kal-1
[R159T+R161L] construct. 179y-GAL4 driven expression
of this mutant protein induced lethality, and delay of
hatching as the wild type DmKal-1 protein (data not
shown). The head skeleton also showed the same defects
as those induced by the wild type protein (Fig. 3E). These
observations indicate that the destruction of this heparan-
sulfate binding site consensus neither affects the binding
to the cell surface nor the in vivo activity of the protein. A
possible explanation might be the redundancy of
heparan-sulfate binding sites, but another possibility is
the dispensability of this site in the particular context in
which the protein has been tested.
Effects of mutant DmKal-1 proteins on wing development
Finally, we decided to test whether the effects of the
mutant DmKal-1 proteins might be reproduced in a dif-
ferent tissue. The data obtained by overexpression in the
head skeleton suggested that the activity of the different
DmKal-1 domains are, at least in part, dispensable. The
dispensability of the WAP domain in some context has
been hypothesized to explain the case of a patient with the
C163Y mutation in the WAP domain, who showed a rela-
tively well conserved sexual phenotype and hormone lev-
Table 1: Lethality and HI defects in DmKal-1 and DmKal-1 
[N236K] larvae.
transformant lines lethality (number) HI defects
DmKal-1 (12) 31% (139) 0%
DmKal-1 (30) 32% (198) 0%
DmKal-1 (47) 43% (226) 0%
DmKal-1 (II and III) 72% (193) 0%
DmKal-1 [N236] (12A) 28% (230) 9%
DmKal-1 [N236] (13) 80% (123) 24%
DmKal-1 [N236] (10B) 85% (192) 22%
DmKal-1 [N236] (1B) 86% (102) 37%BMC Genetics 2006, 7:47 http://www.biomedcentral.com/1471-2156/7/47
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els [28]. We chose the wing disc, because alterations in the
developmental program of this organ are easily detectable
in adult flies. We decided to use the MS1096-GAL4 driver
[29] to express the wild type form of DmKal-1 in the
whole wing disc. We detected a variety of defects, which
were depending on the expression level and therefore
Cellular localization and western blot analysis of wild type and fibronectin mutant forms of DmKal-1-Myc in COS-7 transfected  cells Figure 4
Cellular localization and western blot analysis of wild type and fibronectin mutant forms of DmKal-1-Myc in 
COS-7 transfected cells. (A, B, C) Confocal analysis on unpermeabilized cells. DmKal-1-Myc proteins were detected by 
monoclonal 9E10 antibody. (A) DmKal-1-Myc is secreted from the transfected cells and bind to the cell surface. (B) DmKal-1-
Myc [N236K] localizes on the cell surface of the transfected cells. (C) Dmkal-1-Myc [R159T+R161L] localizes on the cell sur-
face of the transfected cells. (D) Western blot analysis of recombinant Dmkal-1-Myc proteins performed using the polyclonal 
ab9106-100 antibody. Recombinant DmKal-1-Myc proteins present in the cell extracts (cell extr.), in the wash with fresh 
medium (wash), in the wash with 100 μg/ml heparin (wash + hep.), and in the conditioned medium prior of the washes 
(medium). The intensity of the lower band varied in different experiments.BMC Genetics 2006, 7:47 http://www.biomedcentral.com/1471-2156/7/47
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modified by increasing the temperature or the copy
number. Because the high variability in the intensity of
the different phenotypes among the different lines of each
construct, we took in account only qualitative differences.
At low temperature (18°C), P [UAS-kal-1] transgenic lines
did not show any appreciable phenotype (data not
shown), while the P [UAS-kal-1]II and III line showed a
slight reduction of the proximal-distal (P-D) axis of the
wing and a reduction of the L2-L3 intervein territory,
often leading to the fusion of the two veins (Fig. 6A, B).
We also found an appreciable lethality during the pupal
stage. At 25°C, P [UAS-kal-1] transgenic lines showed
splitting of the L4 vein into anterior and posterior
branches with low penetrance (Fig. 6C). At the same tem-
perature (25°C), the P [UAS-kal-1]II and III line showed a
high lethality with only some escapers showing a dra-
matic reduction of the whole wing (Fig. 6D). The specifi-
city of these phenotypes was also in this case tested
expressing Nrg180 in the wing disc. At 25°C, we detected a
reduction of the P-D axis of the wing (Fig. 6J) suggesting
that this alteration may depend on an unspecific effect of
the fibronectin domains. On the other hand, we did not
find any reduction of intervein territory and or splitting/
fusion of veins, suggesting that these phenotypes are spe-
cifically related to the expression of DmKal-1.
We then tested all the Dmkal-1 mutant forms. The two
deleted proteins, one lacking all the fibronectins (W200-
STOP) and the other one truncated in the C-terminal
region (H384-STOP), did not induce any phenotypes also
at 28°C (data not shown), confirming that the missing
parts are indispensable for the function or for the stability
of the protein. DmKal-1 [N236K] induced a phenotype
similar to the wild type form (Fig. 6E). Same lines showed
high lethality and strong reduction of the whole wing also
at 18°C (data not shown). In this organ, however, we did
not find appreciable qualitative differences in respect to
that induced by the wild type protein. This indicated that,
in the context of the wing, the N236K substitution does
not confer to the protein the ability to induce new pheno-
types. At 18°C, DmKal-1 [R159T+R161L] induced only a
small reduction of the P-D axis, with no other visible
defects (data not shown). At 25°C, we found a stronger
reduction of the P-D axis and, frequently, splitting of the
Evolutionary conservation of the heparan-sulfate binding site of the first FnIII domain Figure 5
Evolutionary conservation of the heparan-sulfate binding site of the first FnIII domain. Amino acid sequence align-
ment of the first FnIII domain of different anosmin-1 proteins. An heparan-sulfate binding motif is conserved in the C-terminal 
part of the domain in all vertebrates, in C. elegans and in A. mellifera. In D. melanogaster, a complete heparan-sulfate binding motif 
is present at the N-terminus while, in A. mellifera, only a partially conserved motif is present in this region. In bold, the basic 
residues inside the motif. In the box, the asparagine at position 267 of the human protein and the equivalent amino acid in the 
other species.BMC Genetics 2006, 7:47 http://www.biomedcentral.com/1471-2156/7/47
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Wing phenotypes induced by overexpression of wild type and mutant DmKal-1 proteins in the wing disc Figure 6
Wing phenotypes induced by overexpression of wild type and mutant DmKal-1 proteins in the wing disc. (A, B, 
E, G, H) Wings derived from flies emerged at 18°C. (A) MS1096-GAL4/+ control wing with designations of longitudinal veins 
(L1-L5). (B) MS1096-Gal4/+; UAS-kal-1/+; UAS-kal-1/+ wing shows a slightly shorter proximal-distal axis with a reduction of 
the L2-L3 intervein territory and a partial fusion of the L2 and L3 veins (black arrow). (C) Higher magnification of an MS1096-
Gal4/+; UAS-kal-1/+ wing (25°C), with splitting of the L4 vein into anterior and posterior branches. The arrow indicates the 
anterior branch. (D) At 25°C, MS1096-Gal4/+; UAS-kal-1/+; UAS-kal-1/+ flies show a stronger phenotype with an extremely 
reduced wing. (E) MS1096-Gal4/+; UAS-kal-1 [N236K]/+ wing, which shows a partial fusion of the L2 and L3 veins (black 
arrow). The break of the anterior and posterior cross-veins (white arrows) and the reduction of the distal L5 vein (white 
arrowhead) are also found in the control. (F) At 25°C, MS1096-Gal4/+; UAS-kal-1 [R159T+R161L]/+ wing shows a notched 
edge between L3-L5 veins. (G) MS1096-Gal4/+; UAS-kal-1 [C127/128S]/+ wing. (H) MS1096-Gal4/+; UAS-kal-1 [C127/
128S+N236K]/+ wing. (I) At 25°C, MS1096-Gal4/+; UAS-kal-1 [C85S]/+ wing shows a proximal-distal reduction and the split-
ting of the L4 vein (arrows). (J) At 25°C, MS1096-Gal4/+; UAS-Nrg180/+ wing shows a proximal-distal shortening. All wings 
are from females and they are oriented with anterior upwards and proximal to the left.BMC Genetics 2006, 7:47 http://www.biomedcentral.com/1471-2156/7/47
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L4 vein (data not shown). Reduction of the L2-L3
intervein region was only occasionally found, while we
detected with higher frequency wings showing the edge
between L3 and L5 notched, (Fig. 6F). We never found
this phenotype when we expressed a single dose of wild
type or other mutant DmKal-1 proteins, but we found this
phenotype with low penetrance when we expressed P
[UAS-kal-1]II and III at 18°C (data not shown). The expres-
sion of DmKal-1 [C127/128S] and DmKal-1 [C127/
128S+N236K] induced the same phenotypes as the wild
type protein (Fig. 6G, H), suggesting that the activity of
the WAP domain is dispensable also in this context. The
expression of Dmkal-1 [C85S] at 18°C and at 25°C
caused milder phenotypes, but often we found a broad
splitting of the L4 vein (Fig. 6I).
Discussion
In the present work, we report the first functional charac-
terization of DmKal-1. We show that DmKal-1, like its
orthologs analyzed until now, is secreted in the extracellu-
lar space where it localizes on the cell surface and, in
greater amount, accumulates in the medium (Fig. 4A,
4D). Dmkal-1 is detected on the cell surface of transfected
COS7 cells, but this binding appears particularly weak,
since the protein is easily released after simple substitu-
tion of the medium. Only a small amount of protein is
further released washing the cells or after addition of
heparin (Fig. 4D). DmKal-1 has less FnIII domains in
respect to the human ortholog, and this may explain the
weakness of the binding to the cell surface.
Using an overexpression approach, we also demonstrate
that DmKal-1 is able to alter the cephalopharyngeal skel-
eton formation (Fig. 1D, E) and to determine strong
defects during wing development (Fig. 6A, B, C, D). Inter-
estingly, there is a tight correlation between the head skel-
eton phenotype induced by kal-1 overexpression and the
wild type kal-1 expression profile in the gnathal region. In
C. elegans, a CeKal-1 loss of function mutation as well as
CeKal-1 overexpression produce ventral closure and male
tail defects [11]. These defects are due to the disruption of
correct cell contacts and shapes during epithelial morpho-
genesis. We propose that incorrect contacts among cells
may be responsible for incorrect secretion of the chitinous
material necessary for the formation of the head skeleton,
when DmKal-1 is overexpressed. A kal-1 mutant allele will
be necessary to confirm this hypothesis.
The elimination of all the FnIII repeats produces a protein
completely lacking activity in vivo [12] (and present
study). We have also shown that the elimination of the C-
terminal region of DmKal-1, which contains a putative
heparan-sulfate binding site, completely suppresses the
activity of the protein. It has been showed that the reduc-
tion of the number of FnIII repeats determines a weaker
cell surface association and a lower heparan-sulfate bind-
ing affinity [30]. We can not exclude, however, that the
Drosophila Kal-1 protein looses its stability when these
deletions are produced. We need to obtain a specific anti-
body to exclude this possibility. The N236K mutation in
the first FnIII domain of DmKal-1, which mimics a muta-
tion at an equivalent position identified in a human KS
patient [20], produces additional phenotypes compared
to the wild type protein. In fact, the expression of this
mutated form of DmKal-1 has a stronger effect and also
induces defects in HI and GBR processes (Fig. 3A, G). It is
also interesting to note that, in the wing, DmKal-1
[N236K] overexpression is instead similar to that of the
wild type protein (Fig. 6B, E). This suggests that the func-
tion of the FnIII domains change in respect to the tissue
under examination. The binding activity of DmKal-1 is
not impaired by the N236K substitution (Fig. 4B, D), and
this is different to the effects produced by an equivalent
mutation introduced in CeKal-1 [12]. In C. elegans, there
is a tight correlation between the loss of adhesion and the
partial loss of function of the protein. We can, however,
exclude that the different phenotype depends on the dif-
ferent location of the heparan-sulfate binding site in the
first FnIII repeat. In fact, the elimination of the heparan-
sulfate binding site consensus in DmKal-1 does not
induce a loss of adhesive property (Fig. 4C, D) and a loss
of function in vivo (Fig. 3E and 6F). Two new missense
mutations were found in the first FnIII repeat (V263G and
R262P) that causes the Kallmann's Syndrome, confirming
the importance of this region for the function of the pro-
tein [30,31]. Nevertheless, these mutations do not com-
pletely impair the function of the protein [12], and may
also confer new activities in some contexts (Fig. 3A, G). It
is interesting to note that the elimination of the heparan-
sulfate binding site consensus in the first FnIII repeat
modifies the activity of the protein in the wing disc but
not in the cephalopharyngeal skeleton, again emphasiz-
ing the relevance of the extracellular context for the pro-
tein activity.
Mutations in the CR region or in the WAP domain did not
cause loss of function of DmKal-1 in respect to its ability
to induce head skeleton phenotypes (Fig. 3B, D) or to
alter wing development (Fig. 6G, I). Even if our data sug-
gest that the cysteine-serine substitution in the CR region
might cause a reduction in DmKal-1 protein activity, the
overexpression of both DmKal-1 [C85S] and DmKal-1
[C127/128S] proteins results in phenotypes similar to the
wild type. A C163Y substitution in the WAP domain was
found in one patient affected by KS in which the sexual
phenotype and the sexual hormone levels were well con-
served [28]. It has been suggested that the WAP domain is
dispensable for some of the biological activities of the
KAL-1 protein, at least in the GnRH production. Our data
are in agreement with this hypothesis.BMC Genetics 2006, 7:47 http://www.biomedcentral.com/1471-2156/7/47
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The double substitution C127/128S+N236K, in which the
additional phenotype induced by the N236K substitution
is suppressed by the mutation of the WAP domain (Fig.
3C), indicates interdependence between the function of
the WAP domain and of the FnIII repeats. This suggests
that the function of the WAP domain is in some way
linked to the function of the fibronectins. It is possible to
hypothesize that the WAP domain, and possibly the CR
region, has a regulatory role in respect to the fibronectins.
We envision that the WAP domain, but also the CR
region, may interfere with the adhesive property of the
FnIII repeats, facilitating or preventing the interaction
with heparn-sulfates or other interacting molecules Con-
sistent with this hypothesis is the finding that the muta-
tion of the WAP domain of CeKal-1 abrogated the
heparan-dependent binding activity of the protein [12].
On the other hand, the C172R substitution in the WAP
domain of the human ortholog does not alter the
heparan-sulfate binding characteristics of the protein
[30]. Even though these data appear contradictory, it is
possible to imagine that the adhesive property of anos-
min-1 depends also on the extracellular matrix composi-
tion that is in turn different in diverse tissues. The
adhesive property of anosmin-1 to the cell surface may
change in different cells, as well as the contribution of the
WAP domain and of the CR region may therefore be
essential in some extracellular matrix contexts but nones-
sential in others.
Conclusion
Overexpression of proteins bearing point mutations that
alters the different domain of DmKal-1 in two different
tissue, the cephalopharyngeal skeleton of the embryo and
the wing disc, suggests that the relevance of each domain
is dependent on the extracellular contexts. We suggest that
FnIII repeats have the main role for the activity of the pro-
tein, while the CS region and the WAP domain have only
a modulator role. These data may help to understand the
effect of point mutations affecting the different domains




Drosophila melanogaster stocks were maintained at 25°C
on standard medium. y, w67c23 has been used as control
and also for the production of the transgenic lines carrying
the different constructs. Several independent lines of each
pUAST construct were obtained by P-element germ-line
transformation [33] and at least tree different lines were
analyzed for the wild type and each mutant. The 179y-
GAL4 and UAS-GFP lines were obtained from Blooming-
ton Stock Center. UAS-Nrg180 stock was gently provided
by Luis Garcia-Alonso, and the MS1096-GAL4 line by
Daniela Grifoni.
In situ hybridization and immunohistochemistry
In situ hybridization and immunohistochemistry experi-
ments were performed with minor modifications as
described by [34]. Antisense DIG labeled RNA, corre-
sponding to the full-length cDNA, was used as a probe.
For the immunohistochemistry experiments, anti-Hind
1G9 (Developmental Studies Hybridoma Bank) mouse
monoclonal antibodies were used at 1:100.
Generation of kal-1 and kal-1-myc constructs
Mutated forms of kal-1 and kal-1-myc were produced by
the QuikChange Site-Directed mutagenesis Kit (Strata-
gene), using appropriated oligonucleotide primers. Full
coding region of kal-1 cDNA and mutated forms of kal-1
were inserted into the EcoRI-XhoI restriction sites of the
pUAST tranforming vector [24]. kal-1-myc was obtained
cloning a PCR product in into the EcoRI-SalI sites of the
pMT21 transformation vector containing the c-myc
epitope [35]. Primer sequences are available from the
authors upon request.
Preparation of embryonic cuticle and fly wings
179y-GAL4 flies were crossed with the different UAS lines
at 28°C. For the determination of the lethality, stage 17
embryos were collected and counted after 48 hours.
Embryos were dechorionated in 50% bleach and counted.
For the morphological analysis, after dechorionation, the
embryos were mounted in Hoyer's solution cleared for
several days at 65°C [36]. Adult wings were dissected and
dehydrated in ethanol, mounted in lactic acid/ethanol
(6:5) [37], and examined under light microscope.
Cell culture
Monkey kidney COS-7 cells were maintained in exponen-
tial growth in Dulbecco's modified Eagle's medium
(DMEM, Highclone) containing 10% fetal bovine serum
(Highclone). All constructs were transfected using Poly-
fect (Qiagen) according to instructions provided by the
manufacturer.
Transfection experiments and western blotting
24 hours after transfection, the serum-containing medium
was replaced with serum-free medium. After 48 hours, the
medium (4 ml) was recovered and the cells were washed
in PBS and left in serum-free medium for 30 min and in
serum-free medium containing 100 μg/ml heparin
(sodium salt) for further 30 min. The medium of the first
wash and the heparin-containing medium were concen-
trated by Centricon YM10 (Millipore, Milano, Italy). After
recovery of the heparin-containing medium, the proteins
were extracted from the cells. Cells were lysed in 50 mM
Tris pH 8, 300 mM NaCl, 1% Triton X-100, supplemented
with protease inhibitors (SIGMA). Samples were sub-
jected to a brief sonication (3 × 15s) and then centrifuged
at 10000 g for 10 min at 4°C to remove cellular debris.BMC Genetics 2006, 7:47 http://www.biomedcentral.com/1471-2156/7/47
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The protein samples were resuspended in SDS sample
buffer (20 mMTris-HCl pH 6.8, 2% SDS, 5% β-mercap-
toethanol, 2.5% glycerol and 2.5% bromophenol blue).
We used the whole sample for the washes with fresh
medium and for the washes with medium containing 100
μg/ml heparin, while we used 1/200 of the growth
medium. The samples were subjected to standard SDS-
PAGE electrophoresis followed by transfer to a polyvinyli-
dene difluoriode membrane (PVDF, Amersham). We used
the anti-myc tag antibody ab9106-100 (abcam) at 1:1000.
This antibody did not reveal any signal in non-transfected
cells. Visualization of antibody binding was carried out
with the enhanced chemoluminescence (ECL PLUS) rea-
gent according to the manufacturer's protocol (Amer-
sham). Horseradish peroxidase (HRP)-conjugated
antibodies were from Amersham Pharmacia (1:5000).
Immunofluorescence
For immunofluorescence experiments, cells were grown
and transfected on coverslips. 48 hours after transfection,
cells were blocked in PBS containing 10% pig serum for
10 min and incubated with the monoclonal anti c-myc
(9E10) supernatant for 1 h at 37°C. Cells were then fixed
for 10 min with a solution of 4% paraformaldehyde in
PBS, and incubated with FITC anti-mouse Ig (DAKO) at
1:200 for 1 h at RT. Coverslips were mounted with
Vectashield (DBA) and examinated with a confocal micro-
scope (Biorad).
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